Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

Saphnelo will compete in the market most closely with GlaxoSmithKline's BLyS inhibitor Benlysta (belimumab), which has been available in the EU to treat SLE since 2011 and recorded worldwide sales ...

In the United States, SLE treatment trends between 2007 and 2023 show a continued reliance on glucocorticoids, despite advances in steroid-sparing agents.

General tone of the webpage. Of the final sample of 1093 webpages, 514 were pro-vaccination (47 %), 471 were anti-vaccination (43 %), and the residual 108 were neutral or with an undefined tone ...

A woman’s risk for blood clots varied by the type of hormonal contraception used, according to a nationwide cohort study conducted in Denmark.

Background Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials ...

Abstract Background Patients with psoriatic arthritis (PsA) experience reduced physical function and impaired quality of life. Better patient-reported functional outcomes are found when lower disease ...